ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,273
Screening encounters
5,107
Diagnostic referrals
968
Outstanding pathways
323

Screening pathway

  1. Screening5,107Encounters
  2. Positive finding1,762Documented findings
  3. Referral968Diagnostic referrals
  4. Follow-up1,168Diagnostic visits
  5. Outcome645Resolved pathways

Stage totals use different units. Pending pathways: 323. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0761 · EXP-0761Synthetic · Site B

Full participant history through 2027-02-10, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-24

Referral-time risk

No matching referral was available at this observation date.

Screened participants

4273 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0780 · Expanded synthetic participant 0780Site D — Community Engagement Programme
EXP-0781 · Expanded synthetic participant 0781Site B — Peri-Urban Access Programme
EXP-0782 · Expanded synthetic participant 0782Site D — Community Engagement Programme
EXP-0783 · Expanded synthetic participant 0783Site E — Resource-Constrained Navigation Programme
EXP-0784 · Expanded synthetic participant 0784Site A — Urban Referral Hub
EXP-0785 · Expanded synthetic participant 0785Site E — Resource-Constrained Navigation Programme
EXP-0787 · Expanded synthetic participant 0787Site D — Community Engagement Programme
EXP-0788 · Expanded synthetic participant 0788Site D — Community Engagement Programme
EXP-0789 · Expanded synthetic participant 0789Site E — Resource-Constrained Navigation Programme
EXP-0790 · Expanded synthetic participant 0790Site E — Resource-Constrained Navigation Programme
EXP-0791 · Expanded synthetic participant 0791Site E — Resource-Constrained Navigation Programme
EXP-0792 · Expanded synthetic participant 0792Site A — Urban Referral Hub
EXP-0793 · Expanded synthetic participant 0793Site C — Rural Outreach Programme
EXP-0794 · Expanded synthetic participant 0794Site B — Peri-Urban Access Programme
EXP-0795 · Expanded synthetic participant 0795Site D — Community Engagement Programme
EXP-0796 · Expanded synthetic participant 0796Site C — Rural Outreach Programme
EXP-0797 · Expanded synthetic participant 0797Site B — Peri-Urban Access Programme
EXP-0798 · Expanded synthetic participant 0798Site D — Community Engagement Programme
EXP-0799 · Expanded synthetic participant 0799Site B — Peri-Urban Access Programme
EXP-0800 · Expanded synthetic participant 0800Site E — Resource-Constrained Navigation Programme
EXP-0802 · Expanded synthetic participant 0802Site C — Rural Outreach Programme
EXP-0803 · Expanded synthetic participant 0803Site D — Community Engagement Programme
EXP-0804 · Expanded synthetic participant 0804Site C — Rural Outreach Programme
EXP-0805 · Expanded synthetic participant 0805Site A — Urban Referral Hub
EXP-0806 · Expanded synthetic participant 0806Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1930
HPV DNA
2465
Cytology
712

Navigation activity

Barrier documented
875
Contact attempt
1410
Navigation intervention
381
Diagnostic booking
1206
Diagnostic visit
1168

Documented barriers

Contact difficulty
281
Transport difficulty
287
Appointment coordination
307

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.